Zur Rose Group AG, the largest e-commerce pharmacy in Europe, successfully placed a 2.50% CHF 200,000,000 public straight bond. The bond will be listed at the SIX Swiss Exchange and has a tenor of 5 years. The net proceeds of the bond will be used by Zur Rose Group AG primarily to finance initiatives related to the introduction of the electronic prescription in Germany and for general corporate purposes.
The expected settlement date of the bond is November 21, 2019. Credit Suisse AG acted as sole lead manager with respect to the placement and issuance of the bond. Raiffeisen Switzerland and Zürcher Kantonalbank acted as co-managers.
Baker McKenzie advised Zur Rose Group AG on all legal aspects of this bond issuance. The Baker McKenzie team was led by partner Matthias Courvoisier (Capital Markets) and comprised associates Philip Spoerlé (Capital Markets), Yves Mauchle (Capital Markets) and Beau Visser (Capital Markets) as well as counsel Andrea Bolliger (Tax).